Arcturus Therapeutics Announces Third Quarter 2026 Financial Results and Pipeline Progress
Arcturus Therapeutics Holdings Inc. reported its financial results for the third quarter ended September 30, 2026. Revenue was $18.3 million and $23.3 million for the three and nine months ended September 30, 2026, respectively, compared with $17.2 million and $74.8 million in th
